Your browser doesn't support javascript.
loading
Brentuximab induced CD30+ cutaneous lymphoma responded to anti-PD1 treatment.
Nikolaou, V; Iliakis, T; Marinos, L; Economidi, A; Panayiotidis, P; Rigopoulos, D; Stratigos, A J.
Afiliação
  • Nikolaou V; Dermatology Department, Cutaneous Lymphoma Clinic, Medical School, "A. Sygros" Hospital for Skin Diseases, National & Kapodestrian University of Athens, Athens, 16121, Greece.
  • Iliakis T; Hematology Unit, 1st Propedeutic Department of Internal Medicine, Laikon General Hospital, Medical School, University of Athens, Athens, 11527, Greece.
  • Marinos L; Hemopathology Department, "Evangelismos" General Hospital, Athens, 10676, Greece.
  • Economidi A; Dermatology Department, Cutaneous Lymphoma Clinic, Medical School, "A. Sygros" Hospital for Skin Diseases, National & Kapodestrian University of Athens, Athens, 16121, Greece.
  • Panayiotidis P; Hematology Unit, 1st Propedeutic Department of Internal Medicine, Laikon General Hospital, Medical School, University of Athens, Athens, 11527, Greece.
  • Rigopoulos D; Dermatology Department, Cutaneous Lymphoma Clinic, Medical School, "A. Sygros" Hospital for Skin Diseases, National & Kapodestrian University of Athens, Athens, 16121, Greece.
  • Stratigos AJ; Dermatology Department, Cutaneous Lymphoma Clinic, Medical School, "A. Sygros" Hospital for Skin Diseases, National & Kapodestrian University of Athens, Athens, 16121, Greece.
J Eur Acad Dermatol Venereol ; 33(4): e147-e148, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30520137
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Doença de Hodgkin / Linfoma Cutâneo de Células T / Imunoconjugados / Antineoplásicos Imunológicos / Nivolumabe Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Doença de Hodgkin / Linfoma Cutâneo de Células T / Imunoconjugados / Antineoplásicos Imunológicos / Nivolumabe Idioma: En Ano de publicação: 2019 Tipo de documento: Article